Visit the Caliper Life Sciences web site

Free cancer genes

A Cancer Research UK product story
Edited by the Laboratorytalk editorial team Aug 30, 2004

The Institute of Cancer Research and Cancer Research Technology make European BRCA2 gene patent freely available

The Institute of Cancer Research and Cancer Research Technology (CRT), the technology transfer company of the charity Cancer Research UK, have announced the availability of free licences of European patents on the hereditary breast cancer gene BRCA2 to publicly funded research laboratories and not-for-profit research laboratories.

The patents are based on the pioneering work of Professor Mike Stratton undertaken at the Institute of Cancer Research and funded by CRT's parent charity, Cancer Research UK.

Not what you're looking for? Search the site.

Back to top Back to top

Contact Cancer Research UK

Related Stories

Contact Cancer Research UK

 

Newsletter sign up

Request your free weekly copy of the Laboratorytalk email newsletter ...

Visit the Caliper Life Sciences web site

Search by company

A Pro-talk Publication

A Pro-talk publication